Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

UPC
Universe Pharmaceuticals Inc.
stock NASDAQ

At Close
May 19, 2025 3:59:30 PM EDT
6.29USD+14.572%(+0.80)131,088
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 19, 2025 9:09:30 AM EDT
5.28USD-3.825%(-0.21)1,202
After-hours
May 19, 2025 4:24:30 PM EDT
6.11USD-2.862%(-0.18)1,375
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
08:09AM EST  Universe Pharmaceuticals FY21 Revenue $48M; EPS $0.70   Benzinga
08:00AM EST  Universe Pharmaceuticals INC (the Company) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its financial results for the fiscal year ended September 30, 2021.   GlobeNewswire Inc
Jan 4, 2022
08:23AM EST  Universe Pharmaceuticals INC Announces Strategic Alliance With Jiangxi Province Institute Of Materia Medica To Conduct Research On Traditional Chinese Medicine   Benzinga
08:00AM EST  Universe Pharmaceuticals INC Announces Strategic Alliance with   GlobeNewswire Inc
Dec 29, 2021
08:04AM EST  Universe Pharmaceuticals INC Announces Alliance With Jinggangshan University For Study On Chemical Constituents Of Certain Traditional Chinese Medicine   Benzinga
08:00AM EST  Universe Pharmaceuticals INC Announces Strategic Alliance with   GlobeNewswire Inc
Dec 15, 2021
04:30PM EST  Universe Pharmaceuticals INC (the Company) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company appointedMr. Baochang Liuas its Chief Operating Officer, effective December 1, 2021.   GlobeNewswire Inc
Dec 13, 2021
08:30AM EST  Universe Pharmaceuticals INC Announces Strategic Alliance with   GlobeNewswire Inc
Sep 17, 2021
07:36AM EDT  The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold   Benzinga
Sep 10, 2021
08:00AM EDT  The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test   Benzinga
Aug 19, 2021
10:57AM EDT  The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck   Benzinga
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 2, 2021
08:00AM EDT  Universe Pharmaceuticals INC (the Company) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2021 ended March 31, 2021.   GlobeNewswire Inc
Jul 30, 2021
08:00AM EDT  Universe Pharmaceuticals INC to Announce Unaudited Financial   GlobeNewswire Inc
Jul 29, 2021
08:18AM EDT  The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs   Benzinga
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 26, 2021
08:00AM EDT  Universe Pharmaceuticals INC Hosts Reception for Member of Chinese   GlobeNewswire Inc
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jul 16, 2021
07:37AM EDT  The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study   Benzinga
Jul 15, 2021
08:08AM EDT  The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs   Benzinga
Jul 14, 2021
07:48AM EDT  The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues   Benzinga
Jun 4, 2021
09:39AM EDT  The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact   Benzinga
May 25, 2021
08:09AM EDT  Universe Pharmaceuticals INC Enters into Letter Of Intent For Strategic Cooperation With Kitanihon Pharmaceutical   Benzinga
08:00AM EDT  Universe Pharmaceuticals INC Enters into Letter of Intent for   GlobeNewswire Inc
May 14, 2021
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
May 12, 2021
08:00AM EDT  Universe Pharmaceuticals INC (the Company) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the Company attended West Lake Forum - China Pharmaceutical Industry Development Forum (the Forum) on April 12, 2021 in Hangzhou, China. The Company also exhibited its upgraded version of Guben Yanling Pill at the Forum.   GlobeNewswire Inc
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
Apr 21, 2021
07:31AM EDT  The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue   Benzinga
Apr 16, 2021
08:01AM EDT  The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs   Benzinga
Apr 10, 2021
09:19AM EDT  The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight   Benzinga
Apr 5, 2021
03:12PM EDT  Wrapping Up March With With A Steady Green Streak   Benzinga
Apr 1, 2021
02:37PM EDT  Mid-Afternoon Market Update: Nasdaq Jumps Over 200 Points; AzurRx BioPharma Shares Slide   Benzinga
12:04PM EDT  Mid-Day Market Update: Crude Oil Rises Over 1%; BioXcel Therapeutics Shares Plummet   Benzinga
10:23AM EDT  Shares of Universe Pharmaceuticals INC (UPC) are surging more than 40% Thursday morning at $5.81 after underwriter fully exercised over-allotment option.   RTTNews
10:14AM EDT  Mid-Morning Market Update: Markets Open Higher; CarMax Profit Beats Views   Benzinga
Mar 31, 2021
04:31PM EDT  Universe Pharmaceuticals INC Announces Full Exercise of Underwriter's Over-Allotment Option in the Public Offering   Benzinga
04:30PM EDT  Univest Securities, LLC Announces the Full Exercise of   GlobeNewswire Inc
04:15PM EDT  Universe Pharmaceuticals INC Announces Full Exercise of   GlobeNewswire Inc
Mar 30, 2021
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
Mar 29, 2021
02:34PM EDT  Mid-Afternoon Market Update: Dow Rises 50 Points; Orphazyme Shares Plunge   Benzinga
12:11PM EDT  Mid-Day Market Update: Gold Drops Over 1%; Humanigen Shares Spike Higher   Benzinga
10:11AM EDT  Mid-Morning Market Update: Markets Mostly Lower; Cal-Maine Foods Reports Mixed Q3 Results   Benzinga
09:50AM EDT  Universe Pharmaceuticals INC (UPC) shares are spiking on Monday morning trade, continuing the uptick since the company closed Initial Public Offering last Thursday.   RTTNews
05:14AM EDT  Universe Pharmaceuticals, Which Opened for Trade in its IPO at $5.25 on March 23, Trading Premarket at 14, Up 250%   Benzinga
Mar 26, 2021
07:28AM EDT  The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs   Benzinga
Mar 25, 2021
04:30PM EDT  Univest Securities, LLC Announces Closing of IPO for its Client   GlobeNewswire Inc
04:20PM EDT  Universe Pharmaceuticals INC (the Company) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the closing of its initial public offering (Offering) of 5,000,000 ordinary shares at a public offering price of US$5.00 per ordinary share.   GlobeNewswire Inc
07:58AM EDT  The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut   Benzinga
Mar 23, 2021
10:21AM EDT  Universe Pharmaceuticals Shares Open For Trade At $5.26; IPO Priced At $5/Share   Benzinga
09:40AM EDT  Universe Pharmaceuticals Shares Will Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced At $5/Share   Benzinga
08:50AM EDT  Universe Pharmaceuticals INC Announces Pricing Of IPO At $5/Share   Benzinga
08:50AM EDT  Universe Pharmaceuticals INC Announces Pricing and Trading of   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC